What is Levaquin?
Also known by it’s generic name, Levofloxacin, Levaquin was developed by Daiichi Pharmaceutical Co. Ltd in 1987, and released in Japan in 1993. Approved by the Federal Drug Association (FDA) in 1998, Levaquin is now manufactured the United States by Ortho-McNeal–a subsidiary of Johnson & Johnson. Levaquin’s FDA approved uses include the treatment of bacterial infections of the skin, sinuses, kidney, bladder, or prostate. The drug is also commonly prescribed to kill a bacterium that leads to bronchitis and pneumonia. Common side effects include: chest pain, stomach irritation, headache, and skin reaction.
What are the side effects?
In the United States, millions of people are prescribed Levaquin annually to treat inflammatory diseases, skin infections, and bronchitis; however, more serious side effects have been reported. Nerve damage (peripheral neuropathy), tendon ruptures, and psychiatric conditions (such as depression, anxiety, and insomnia) have been known to appear in some Levaquin users.
Between 2001 and 2006, these side effects were noted by doctors and patients, and several protests concerning a “lack of warning” ensued. In 2008, the FDA issued a black box warning about the potential symptoms. Unfortunately, it may have been too late for many patients. Despite the known dangers, the drug is still available on the market and is prescribed frequently for bacterial infections.
Since 2013, thousands of law suits have been filed against Johnson & Johnson for nerve and tendon damage caused by Levaquin; as of 2015, nearly 100 cases were still being disputed in court.
Settlements of undisclosed amounts have been reached for may of those adversely affected by Levaquin. Find out if you are eligible to file a claim for damages caused by Levaquin or Levofloxacin by filling out our brief questionnaire here.
- Federal Drug Administation